Sagent Pharmaceuticals - PDFSEARCH.IO - Document Search Engine

Sagent Pharmaceuticals
Results: 72

#	Item
1	July 15, Bayer Ups Offer to Acquire Monsanto to Approximately $65 Billion Making its first largescale acquisition since becoming a pureplay life sciences company, Bayer has raised its allc Add to Reading List Source URL: www.dcat.org Language: English - Date: 2016-07-21 12:56:30 Business Pharmacology Pharmaceutical sciences Immunosuppressants Biotechnology Biosimilar Drugs Pharmaceutical industry Pharmacy Adalimumab Etanercept Sagent Pharmaceuticals
2	Sagent Pharmaceuticals, Inc. Wholesaler / Distributor Return Goods Policy Prior Authorization: Prior authorization from Sagent Pharmaceuticals, or Sagent, in the form of a Returned Goods Authorization (RGA), is required Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-11-21 21:11:48 Sagent Advisors Returning Invoice Purchasing Packaging and labeling Business Technology Retailing
3	Sagent Pharmaceuticals, Inc. Vancomycin Hydrochloride for Injection, USP Safety Data Sheet (SDS) Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2015-03-05 16:31:11 Eli Lilly and Company Glycopeptide antibiotics Globally Harmonized System of Classification and Labelling of Chemicals Hazard analysis Material safety data sheet Vancomycin GHS hazard statement SDS-PAGE Safety Health Chemistry
4	Sagent Pharmaceuticals, Inc. Topotecan Hydrochloride for Injection Safety Data Sheet (SDS) Topotecan Hydrochloride Injection SDS Issue Date: Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-12-19 15:19:31 Lactams Lactones Topotecan Material safety data sheet SDS-PAGE Chemistry Health Safety
5	Sagent Pharmaceuticals, Inc. Wholesaler / Distributor Return Goods Policy Prior Authorization: Prior authorization from Sagent Pharmaceuticals, or Sagent, in the form of a Returned Goods Authorization (RGA), is required Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-11-21 23:27:46 Sagent Advisors Returning Invoice Purchasing Packaging and labeling Business Technology Retailing
6	Sagent Pharmaceuticals, Inc. Ropivacaine HCl Injection, USP Safety Data Sheet (SDS) SDS Issue Date: Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-12-08 11:49:39 Health sciences Industrial hygiene Occupational safety and health Chlorides Material safety data sheet Materials Globally Harmonized System of Classification and Labelling of Chemicals Ropivacaine Hydrogen chloride Chemistry Health Safety
7	Sagent Pharmaceuticals, Inc. Fludarabine Phosphate for Injection, USP Safety Data Sheet (SDS) Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-12-19 15:18:02 Industrial hygiene Health sciences Threshold limit value Fludarabine Globally Harmonized System of Classification and Labelling of Chemicals Material safety data sheet Permissible exposure limit Dose Occupational Safety and Health Administration Safety Health Occupational safety and health
8	Sagent Pharmaceuticals, Inc. Gemcitabine for Injection, USP Safety Data Sheet (SDS) Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2015-01-13 16:21:18 Eli Lilly and Company Gemcitabine Organofluorides Material safety data sheet Median lethal dose SDS-PAGE Methamphetamine Health Chemistry Biology
9	Sagent Pharmaceuticals, Inc. Colistimethate for Injection, USP Material Safety Data Sheet (MSDS) Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-12-08 11:22:33 Safety Health sciences Environmental law Safety engineering Material safety data sheet Occupational hygiene Threshold limit value Health Industrial hygiene Occupational safety and health
10	(Significantly Regulated) Listing of U.S. Industries for Filing Year 2014 Company Safeguard Scientifics, Inc. Safeway Inc. Sage Therapeutics, Inc. Sagent Pharmaceuticals, Inc. Add to Reading List Source URL: www.fda.gov Language: English NASDAQ Biotechnology Index Biopharmaceuticals Oncology Sunesis Pharmaceuticals

UPDATE